ID: h-var-5f0a621982
Hypothesis

Site-Specific TREM2 Fragment Analysis Within Multi-Analyte CSF Panel for Microglial Priming Detection

This hypothesis proposes that incorporating Parent B's mechanistically precise site-specific TREM2 fragment ratio analysis (N-terminal vs C-terminal fragments reflecting ADAM10/17 protease activity) into Parent A's robust multi-analyte f.
🧬 TREM2🩺 biomarkers🎯 Composite 37%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 3 support 2 oppose
✓ All Quality Gates Passed
Mechanistic 0.46 (15%) Evidence 0.35 (15%) Novelty 0.35 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.23 (10%) Safety 0.20 (8%) Competition 0.28 (6%) Data Avail. 0.54 (5%) Reproducible 0.35 (5%) KG Connect 0.53 (8%) 0.368 composite

🧪 Overview

This hypothesis proposes that incorporating Parent B's mechanistically precise site-specific TREM2 fragment ratio analysis (N-terminal vs C-terminal fragments reflecting ADAM10/17 protease activity) into Parent A's robust multi-analyte framework creates a superior biomarker panel for detecting microglial priming states. The approach combines TREM2 fragment ratios with YKL-40 (neuroinflammatory priming) and neurogranin (synaptic vulnerability) using a weighted algorithm that leverages the specific mechanistic information from TREM2 cleavage patterns. Unlike total sTREM2 levels, fragment ratios directly reflect the balance between homeostatic (low cleavage) and activated (high ADAM10/17-mediated cleavage) microglial states. This mechanistic specificity addresses the interpretation challenges of bulk sTREM2 measurements while maintaining the statistical robustness of a multi-marker approach. The panel would use mass spectrometry to quantify specific TREM2 fragments alongside established ELISA-based measurements of YKL-40 and neurogranin.

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["CHI3L1/TREM2/NRGN<br/>Hypothesis Target"]
    B["Synaptic<br/>Cited Mechanism"]
    C["Cellular Response<br/>Stress or Clearance Change"]
    D["Neural Circuit Effect<br/>Synapse/Glia Vulnerability"]
    E["Neurodegeneration<br/>Disease-Relevant Outcome"]
    A --> B
    B --> C
    C --> D
    D --> E
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style B fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix3 supports2 contradicts
Supports
CSF YKL-40 and sTREM2 show distinct temporal patterns in AD progression
Supports
Multi-marker models outperform single biomarkers for AD prediction
Supports
Neurogranin reflects synaptic integrity and predicts progression
Contradicts
Inherits all component limitations; combining nonspecific markers does not create specificity
Contradicts
Overfitting risk with 12 markers and elastic net regression requires stringent validation
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — TREM2

🧬 PDB 6YXY Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for TREM2 from GTEx v10.

Spinal cord cervical c-148.4 Substantia nigra20.7 Hypothalamus10.9 Hippocampus9.8 Amygdala8.9 Caudate basal ganglia7.9 Putamen basal ganglia6.6 Nucleus accumbens basal ganglia6.2 Anterior cingulate cortex BA245.6 Frontal Cortex BA95.1 Cortex3.5 Cerebellar Hemisphere2.9 Cerebellum1.5median TPM (GTEx v10)

💉 Clinical Trials (1)

0
Active
0
Completed
0
Total Enrolled
Unknown·

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for TREM2 →

No DepMap CRISPR Chronos data found for TREM2.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0000
Events (7d)
0

💾 Resource Usage

LLM Tokens
25,530
$0.0766
Total Cost
$0.0766
Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
sourcev1_phase_c_backfill
origin_typedebate_synthesizer
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.